OR7A19P

Across TCGA pan-cancer cohorts, OR7A19P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR7A19P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher OR7A19P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7A19P expression acts as an unfavorable survival marker, although some lineages such as LUAD and LAML show a favorable association.

THCA, LUAD, and LIHC are the cancer types where OR7A19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	III,IV	0.271	0.875	.018	18	view →
LUAD	DFS	Tertile	All	0.763	0.313	.003	18	view →
LIHC	OS	Tertile	All	0.495	0.726	.008	18	view →
ACC	OS	Tertile	IV	0.247	0.777	<.001	18	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →
OV	DFS	Quartile	IV	0.330	0.493	.047	6	view →
THYM	OS	Tertile	II,III,IV	0.450	0.936	.023	6	view →
LAML	DFS	Tertile	All	0.663	0.429	.035	6	view →
LUSC	OS	Tertile	II,III,IV	0.620	0.378	.048	3	view →
KIRC	OS	Quartile	All	0.760	0.812	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR7A19P–THCA (OS)

Open the THCA breakdown →